MedTrace Logo

Influence of Persistent Food Allergy on Nutritional Status of Children With Food Allergy

NCT05937061 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2023-07-10

No results posted yet for this study

Summary

The goal of this single center retrospective cohort study with observational longitudinal follow up is to compare food - allergic children (egg, milk and peanut allergy) with children in control group (children without any food allergy).

The main question\[s\] it aims to answer are:

* If children with food allergy groups will have lower food intake od micronutrients?
* If growth in children with food allergy is worse as in control group?
* If they are more malnourished and in the food allergies group is more stunting than in the control group?
* If children with milk allergy have lower intake of calcium in their diet and lower mineral bone density?

Participants will be asked to do 3 day food diary and to have blood analysed (hemograme, complete blood count, serum iron status, serum protein).

If there is a comparison group: Researchers will compare milk, egg and peanut allergy group to the control group (peers without food allergy) to see if the food allergy affects growth, macronutrient, micronutrient intake.

Conditions

Interventions

BIOLOGICAL

Blood sample analysis

Analysis of complete blood count, hemogram, serum proteins, serum iron status (iron, transferin, ferritin). Group comparison - intervention vs. control.

OTHER

Anthropometrics measurement - at inclusion to the study (all groups).

Measurement of body height (cm), weight (kg) and calculating BMI (kg/m2). Group comparison - intervention vs. control.

RADIATION

Bone mineral density measurement (DXA)

Analysis of bone mineral density with DXA in patients with milk allegy. Analysis ordered by medical doctor.

OTHER

Influence of food allergy on growth (intervention groups)

Gathering the data about of body height (cm), weight (kg) BMI (kg/m2) at the diagnosis of food allergy and comparison versus data at the enrollment in the study to asses growth.

Sponsors & Collaborators

  • University Medical Centre Ljubljana

    lead OTHER

Principal Investigators

  • Tadej Avcin, prof. · Head of Department of Clinical Immunology, Rheumatology and Allergology

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2022-06-30
Completion
2022-12-31

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05937061 on ClinicalTrials.gov